Key infrastructure from R&D through clinical trials and manufacturing
Expanding global cooperation and investment attraction

Siheung, Gyeonggi Province, is promoting the strengths of its AI-bio convergence cluster and seeking investment from domestic and international pharmaceutical and biotechnology companies and investment institutions.

The Siheung AI-Bio Convergence Cluster promotional booth at BioPlus-Interphex Korea 2026. Provided by Siheung City.

The Siheung AI-Bio Convergence Cluster promotional booth at BioPlus-Interphex Korea 2026. Provided by Siheung City.

View original image

Siheung City, headed by Mayor Lim Byeongtaek, announced on October 29 that it is participating in BioPlus-Interphex Korea 2026 (BIX 2026), being held at COEX in Seoul from October 28 to 30, and operating a pavilion showcasing key infrastructure and development strategies for the AI and bio industries.


BIX is a business event for the bio industry, bringing together domestic and international pharmaceutical and biotechnology companies, hospitals, research institutions, and investment institutions. It provides a venue to share industry trends and explore opportunities for cooperation through exhibitions and conferences.


The city has set up its pavilion under the theme “Siheung, Gyeonggi Province: An Innovation Hub Shaping the Future of Korea’s AI and Bio Industries.” Its exhibits cover five areas: ▲the full-cycle K-bio innovation ecosystem; ▲key infrastructure for AI-bio convergence centered on Seoul National University’s Siheung Campus; ▲a next-generation clinical hub based on AI and medical data; ▲strategies to develop the AI- and robot-based bio materials, parts, and equipment industries; and ▲support programs for companies attracting investment.


The pavilion places particular emphasis on the bio industry ecosystem spanning research and development, clinical trials, validation, and manufacturing, as well as strategies to develop industries by incorporating AI technologies. The city aims to highlight the strengths of its bio-specialized complex and the potential for growth through AI convergence.


Domestic and international companies and investment institutions are being briefed on Siheung’s location advantages and business support programs. On-site consultations and networking are also helping expand opportunities for cooperation among companies and for attracting investment.


The Siheung Bio Global Bridge Forum will be held on October 29 at the open stage in Hall C of COEX. The forum will share the vision for the Siheung, Gyeonggi Province, bio cluster and strategies for entering global markets, drawing on the example of Basel, Switzerland. The city also plans to sign business agreements with the Siheung Industry Promotion Agency and domestic and international partner organizations to support the growth and overseas expansion of bio companies.



A Siheung City official said, “This event is an opportunity to showcase Siheung’s key AI and bio infrastructure and its potential for industrial growth to domestic and international companies and investors. We will strengthen cooperation among industry, academia, research institutions, and hospitals, and expand our global network and investment attraction efforts to develop Siheung into Korea’s leading innovation hub for AI and bio.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.